Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v2-FR
Language French French
Date Updated 2017-10-05 2017-03-23
Drug Identification Number 02262347 02262347
Brand name NIASPAN NIASPAN
Common or Proper name Extended-release niacin Extended-release niacin
Company Name SUNOVION PHARMACEUTICALS CANADA INC SUNOVION PHARMACEUTICALS CANADA INC
Ingredients NICOTINIC ACID NICOTINIC ACID
Strength(s) 500MG 500MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30 Bottles of 30
ATC code C10AD C10AD
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2016-09-28 2016-09-28
Actual start date
Estimated end date Unknown Unknown
Actual end date 2017-03-31
Shortage status Resolved Actual shortage
Company comments This product was discontinued on March 31, 2017. Please note that NIASPAN FCT® (extended-release film coated tablets) 500 mg and 1000 mg will remain on the market. Will be discontinued as of March 31, 2017. Please note that NIASPAN FCT® (extended-release film coated tablets) 500 mg and 1000 mg will remain on the market.
Health Canada comments